Skip to main content Skip to main navigation menu Skip to site footer

Penggunaan obat anti-inflamasi nonsteroid pada anak


We know that non-steroid anti-inflammatory drugs (NSAID) have analgetic, antipirettanand anti-inflammatory effect. This drugs can decrease pain simptomaticly, the most widelyprescribed drugs worldwide and being the drugs of first choice other inflammatory pain.There is many kind NSAID that we knaw, like aspirin, parasetamol, ibuprofen, mefenamicacid, endometasin, diklofenak, piroksikan and nemosulide. Every kind of NSAID has itsadvantage and dis advantage for that beneficial actions and side effects. That beneficialactions and harmful side effects of NSAID can be associated with its mechanism of action.Using NSAID for children must in attention. This article is expented to give informationand to help the collegnes in the selecting drugs NSAID for child.


  1. Radde C, Macleod SM. Pediatric pharmacology and therapeutics. 2nd
  2. edition. Jakarta: Hipocrates; 1998. p. 665-7.
  3. Vane JR, Botting RM. Inhibition of prostaglandin syntheses as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232-5.
  4. Goodman. Gillman’s: The pharmacological basis of therapeutics. 8th edition. Millan Publishing Company; 1990. p. 207-300.
  5. Lelo A. NSAIDS: Friend or foe. J Persatuan Dokter Gigi Indonesia 2005; Edisi Khusus Kongres Nasional ke-22, Makassar, Maret 2005.
  6. Sala A, Folco G. Actual role of prostaglandin in inflammation. In: Drug invest; 1999. p. 4-9.
  7. Motola D, Vaccheri A, Silvani MC, Poluzzi E. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol 2004; 60(10): 731-8.
  8. Davier P, Bailey PJ, Coldenberg M, FordHutchchinson AW. The role of arachidonic acid oxigenation products in pain and inflammation. Ann Rev Immunal 1984; 2:335-57.
  9. Velo GP. The anti-inflammatory analgesic and antipyretic activity of nimesulide. In: Drug Invest, 1991. p.10-3.
  10. Colberg K, Hettich M, Sigmund R, Degner FL. The efficacy and tolaberability of an 8day administration of intravenosus and oral meloxicam: a comparison with intra muscular and oral diclofenac inpatient in acute lumbago. Curr Med Res Opin 1996; 13: 363-77.
  11. Subagyo RL. Selection NSAID for Clinical Situation; 2000. p. 8-11.
  12. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. J Am Med Assoc 2001; 286: 954-9.
  13. Nelson WE, Behrman RE, Nelson. Ilmu kesehatan anak. Alih bahasa: Samik Wahab, Edisi 15. Vol 1. Jakarta:EGC; 2001. p.362-6
  14. __________. Terapi obat pada pasien pediatri. Available at Diakses: 7 April 2006.
  15. Neidle EA, Kroeger DC, Yogiela JA. Pharmacologic and therapeutic for dentistry. London: The CV Mosby Company; 1980. p. 69-70.
  16. Bennett PN, Brown MJ. Clinical pharmacology. Edisi 9. Churchill Livingstone; 2004. p.125.
  17. Craig CR, Stitzel RE. Modern pharmacology with clinical applications. 6 edition. Lippincott Williams and Wilkins Company; 2001. p. 362-6.

How to Cite

Fajriani, F. (2008). Penggunaan obat anti-inflamasi nonsteroid pada anak. Journal of Dentomaxillofacial Science, 7(1), 1–6.




Search Panel

Fajriani Fajriani
Google Scholar
JDMFS Journal